US Liquid Vaccine Filling Solutions Key Players and their Developments

Latest Updates of Companies in the U.S. Liquid Vaccine Filling Solutions Market

Recent Developments in the U.S. Liquid Vaccine Filling Solutions Market

• In May 2026, Syntegon presented a novel line concept for liquid pharmaceuticals. SynTiso was developed in partnership with two partners from the pharmaceutical industry and addresses the current limitation of pharmaceutical manufacturers regarding high performance and availability, as well as maximum product yield and minimal operator involvement.
• In October 2025, Aenova announced a significant investment in its sterile manufacturing capabilities with the installation of another fill & finish line at its Latina site. This development marks an imperative step in meeting the increasing worldwide demand for biologics production.
• In July 2025, Sanofi announced it had agreed to acquire Vicebio Ltd, a privately held biotechnology organization headquartered in London, UK.

Supply Chain Analysis

R&D:

• Research and development (R&D) in liquid vaccine filling solution includes formulation development and stability, primary packaging compatibility, filling process development and optimization, sterilization and aseptic techniques, scale-up and transfer to production, and container closure integrity (CCI) studies
• Key Players: Syntegon and IMA Group

Manufacturing Processes:

• Manufacturing processes involve sterilization, formulation, filling, and sealing in a continuous, often automated, operation.
• Key Players: Optima Packaging Group and Groninger & Co. GmbH

Patient Services:

• Patient services in liquid vaccine filling are significantly focused on ensuring the sterility, safety, effectiveness, and availability of the vaccine.
• Key Players: Dara Pharma and Cozzoli Machine Company

Market Growth

The U.S. liquid vaccine filling solutions market size was estimated at USD 1.42 billion in 2025 and is predicted to increase from USD 1.56 billion in 2026 to approximately USD 3.63 billion by 2035, expanding at a CAGR of 9.85% from 2026 to 2035.